The pharmacokinetics of alfentanil, a new and very short-acting opioid, are discussed. Its use in day-case gynaecological procedures is described, and the results of the initial study presented. Alfentanil is a valuable adjunct to anaesthesia for day-case surgery and for short, painful procedures.
Introduction
Alfentanil is a new potent narcotic analgesic, chemically related to fentanyl but differing from it in certain important aspects. It has a higher degree of protein binding which is much less pH-dependent, and a lower solubility, limiting its penetration into cells and tissues such as fat and muscles (Meuldermans et al. 1982) . This combination of physical properties helps to explain its small volume of distribution, approximately four times smaller than fentanyl (Bovill et al. 1982) , which more than compensates for the smaller clearance rate. This results in a significantly shorter elimination half-life (Bower & Hull 1982) , about 90 minutes compared with 200 minutes for fentanyl, and has led to it being described as a kinetically predictable narcotic (Stanski & Hug 1982) . It has a very rapid onset of action and the shortest duration of effect known for an opioid (Niemegeers & Janssen 1981) . It has been shown to provide good cardiovascular stability (De Lange et al. 1981) .
These characteristics make it equally suitable for long and short procedures, especially in day-case surgery when rapid and complete recovery is highly desirable. It has been used as an induction agent (Spierdijk et al. 1980) , as an infusion for the maintenance of anaesthesia (De Lange et al. 1981 ) and as the analgesic component of balanced anaesthesia with controlled ventilation (Kay 1982) with excellent results, but its use in the spontaneously breathing patient under anaesthesia has proved more difficult due to its short and intense action (Kay & Stephenson 1980 , Hull & Jacobson 1983 . We have used an incremental technique in day-case surgery, and present the initial results. The findings are discussed with reference to other studies from the same unit involving patients having similar day-case surgery.
Methods
Fifty consecutive female patients, aged between 16 and 65 years (mean 26.6), who were under-going day-case surgery gave informed consent to receive alfentanil. All conformed to Grades I (45) or 11 (5) American Society of Anaesthesiologists Classification of physical status, with a weight range of 40.6-92.0 kg (mean 61.2 kg). Patients with malignant disease or with a history of atopy, asthma or previous drug reactions were excluded from the study. The operations are listed in Table 1. No premedication was given. Anaesthesia was induced with alfentanil 0.3-0.5 mg intravenously over 15-20 seconds, followed by a sleep dose of methohexitone, and the patients then breathed 66% N20 in 33% 02 via a Bain circuit. Increments of 0.1-0.2mg alfentanil and 10 mg methohexitone were given as required. Patients having vaginal termination of pregnancy also received oxytocin (Syntocinon; 5 units) intravenously after dilatation of the cervix. Blood pressure, pulse and respiration were recorded every two minutes and particular note was made of apnoea (defined as 30 seconds without spontaneous respiration), limb movement, muscular rigidity and pain on injection. Recovery time was measured as the time from the withdrawal of the nitrous oxide to the patient opening her eyes in response to her name; the time taken to respond to a series of simple questions was also recorded. Patients rested on trolleys until they were able to eat and drink satisfactorily, and were then allowed to go home with an escort.
Results
Induction doses of alfentanil ranged from 0.3 to 0.5 mg. The first 29 patients received 0.5 mg, but because of respiratory depression and occasional apnoea the dosage was reduced to 7,ug/kg, which seemed more appropriate. The induction dose of methohexitone averaged 117 mg (range 50-180 mg). The anaesthetic time ranged from 5 to 16 minutes (mean 10.8). Alfentanil increments were given to all patients (mean 0.4 mg) and methohexitone to 28 (range 10-80 mg, mean 15.8).
Apnoea (60-120 seconds) occurred in 6 of the first 29 patients, but not at all in the last 21, and only one patient required intermittent positive pressure ventilation by mask. No patient showed any involuntary movement during induction but 15 (30%) showed some slight limb movement in response to surgical stimulation, usually unnoticed by the surgeon. Cardiovascular parameters were invariably stable, with no patient showing a difference of more than 10% from preinduction values. Bradycardia was not observed. Anaesthesia was classified as good or fair in all cases except one; this was the second case in the series and was complicated by marked limb movement in response to surgery.
Recovery time averaged 2.35 minutes (range 0-9). The time to answer questions correctly was only slightly longer than this (Table 2 ). Nausea and/or vomiting occurred in 54% of patients.
Discussion
This technique proved to be a very satisfactory way of using alfentanil but, in common with other studies (Kay & Stephenson 1980 , Hull & Jacobson 1983 , it was found that better results were obtained with increasing experience of the drug because its extremely short duration of action differed from that of any other analgesic drug previously used.
Best results were obtained by giving increments of 0.1-0.2 mg at 2-4 minute intervals, depending on the patient's initial response to the drug, the progress of surgery and its effect on respiration. Waiting for an indication of light anaesthesia before giving an increment resulted in very unsatisfactory operating conditions. Cardiovascular stability was a feature of anaesthesia with alfentanil, and the bradycardia occasionally seen with fentanyl was not a problem. Once it was appreciated that the initial dose was too high, apnoea was no longer a problem and when it did occur ventilation was easy and there was no evidence of increase of chest wall rigidity.
It is interesting to compare our recovery time with those of published series from the same unit using other anaesthetic techniques (Table 3) . This rapidity of recovery is important in a busy day-case unit as it ensures the patient's protective reflexes are present as soon as possible and minimizes the work of the recovery room staff. Several patients remarked spontaneously Stanford et al. 1979 Methohexitone and enflurane 5.70 + 2.8 Stanford et al. 1979 Methohexitone and alfentanil 2.35 + 2.0 Present series on their rapid awakening and compared it favourably with previous experiences. None had any recall of the procedure. The incidence of emetic sequelae in this study was similar to that in a comparable series using fentanyl (Hunt et al. 1979 ). This may reflect the known tendency of young women undergoing gynaecological operations to this complication and also the fact that more than half of them were given Syntocinon. The current high incidence (54%) contrasts with a lower figure which we have noted in premedicated patients receiving alfentanil during anaesthesia; perhaps the high plasma level of the narcotic in conscious patients was responsible for this.
It is concluded that alfentanil is a valuable adjunct to anaesthesia for day-case surgery, for short painful procedures and for repeated anaesthetics such as may be required for radiotherapy in children and burns dressings where rapid recovery to normal life and feeding is important. However, its unusually rapid onset and short duration of action may lead to difficulties unless this is fully appreciated. It should not be compared to fentanyl in clinical use, for this would result in not using it to its full potential.
